Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 142 of the 158 references it cites were found in a registry or an index; 50 of the 167 sources its claims cite were checked for support.

Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders

Open access
Chapoutot, Mélinée, Peter-Derex, Laure, Bastuji, Hélène, Leslie, Wendy, Schoendorff, Benjamin, Heinzer, Raphael, Siclari, Francesca, Nicolas, Alain, Lemoine, Patrick, Higgins, Susan, Bourgeois, Alexia, Vallet, Guillaume T., Anders, Royce, Ounnoughene, Marc, Spencer, Jessica, Meloni, Francesca, Putois, Benjamin · 2021 · International Journal of Environmental Research and Public Health

Abstract

Benzodiazepines have proven to be highly effective for treating insomnia and anxiety. Although considered safe when taken for a short period of time, a major risk–benefit dilemma arises in the context of long-term use, relating to addiction, withdrawal symptoms, and potential side effects. For these reasons, benzodiazepines are not recommended for treating chronic sleep disorders, anxiety disorders, nor for people over the age of 65, and withdrawal among long-term users is a public health issue. Indeed, only 5% of patients manage to discontinue using these drugs on their own. Even with the help of a general practitioner, this rate does not exceed 25 to 30% of patients, of which approximately 7% manage to remain drug-free in the long term. Cognitive Behavioral Therapies (CBT) offer a crucial solution to this problem, having been shown to increase abstinence success to 70–80%. This article examines traditional and novel CBT techniques in this regard, such as Acceptance and Commitment Therapy, which address both the underlying condition (insomnia/anxiety) and the substance-related disorder. The theoretical framework and evidence supporting the use of these approaches are reviewed. Finally, current research gaps are discussed, and key research perspectives are proposed. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Overview

CoChat Summary

## TL;DR

This review argues that long-term benzodiazepine withdrawal is difficult and that cognitive behavioral therapy (CBT), including newer forms such as acceptance and commitment therapy (ACT), can improve discontinuation success when paired with tapering. The paper mainly synthesizes prior studies and concludes that CBT should be used before and during deprescribing for patients with insomnia or anxiety disorders.

## Key findings

  • The paper states that only 5% of patients discontinue benzodiazepines on their own, and that with a general practitioner the rate rises to 25–30%, with about 7% remaining drug-free long term.
  • In the reviewed literature, brief interventions for discontinuation had an overall success rate of 25–40%, versus 5% for waiting list or treatment as usual.
  • The paper reports eight RCTs comparing taper alone vs taper plus CBT, plus two publications with long-term outcomes; among these, five out of seven studies showed greater success with CBT plus tapering.
  • Specific examples reported for CBT plus tapering include: panic disorder (80% vs 40%, 75% vs 23%, 62.5% vs 12.5% at 6 months), generalized anxiety disorder (75% vs 35% at 12 months), insomnia (85% vs 48% and 70% vs 25% at 12 months), and panic disorder at 24 months (75% vs 30%). For insomnia, relapse was still seen at 5 years, but benefit remained (50% vs 32%).

## Methods

  • Narrative review of the theoretical and clinical-trial evidence on CBT and ACT for discontinuing long-term benzodiazepine use in insomnia and anxiety disorders.
  • The authors searched Medline, PsycINFO, and the Cochrane Collaboration Central Register of Controlled Trials in November 2020, and also used citations from studies, reviews, and meta-analyses of benzodiazepine-reduction interventions.
  • The review synthesized RCTs and meta-analyses on taper programs, CBT, and ACT, with attention to insomnia, anxiety disorders, withdrawal, and abstinence outcomes.

## Limitations

  • The paper explicitly states that studies on CBT interventions are scarce: nine RCTs over 30 years of research, and that the number of studies on ACT for benzodiazepine withdrawal is insufficient to establish a recommendation.
  • It also states that no study has assessed the effectiveness of ACT on BZD withdrawal as a primary outcome, and that evidence for ACT in this area is limited to one pilot study for insomnia associated with sleeping pill addiction.
  • Evident from the text: this is a review, not a new clinical trial, so its conclusions depend on the quality and heterogeneity of the included studies; the paper itself notes that withdrawal programs, follow-up duration, and patient definitions vary greatly across studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijerph181910222

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

32 Valid · 11 Not valid · 49 Not checked · 43 Own results and interpretations

47 more claims · 9 with their cited sources checked

Create a free account to see all 135 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 56
  • Probably not a substantial claim. 46

Create a free account to see these claims.

Citations

Cites

Show all 158 references

Research works printed but not linked: 5

  1. Group, B., and Press, P. (2017). British National Formulary, National Institute of Clinical Excellence.
  2. (2021, March 09). Canadian Agency for Drugs and Technology in Health Discontinuation Strategies for Patients with Long-Term Benzodiazepine Use: A Review of Clinical Evidence and Guidelines, Available online: http://www.ncbi.nlm.nih.gov/pubmed/26290934.
  3. Morin, C.M. (1993). Insomnia: Psychological Assessment and Management, Guilford Press.
  4. Barlow, D., and Crask, M. (1989). Mastery of Your Anxiety and Panic, Graywind Press.
  5. Hayes, S.C., Strosahl, K., and Wilson, K.G. (1999). Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change, Guilford Press.

Cited by

See all 59

Metadata

Authors
Chapoutot, M., Peter-Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R., Siclari, F., Nicolas, A., Lemoine, P., Higgins, S., Bourgeois, A., Vallet, G. T., Anders, R., Ounnoughene, M., Spencer, J., Meloni, F., & Putois, B.
Affiliations
  • Lyon 1 Université (FR)
  • Association Nationale de Promotion des Connaissances sur Le Sommeil, 69001 Lyon, France
  • Xceltranslate, 06000 Nice, France
  • Institut de Psychologie Contextuelle, Montreal, QC H2Y 2S9, Canada
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Centre Hospitalier Annecy Genevois (FR)
  • University of Geneva (CH)
  • Centre National de la Recherche Scientifique (FR)
  • Université Lumière Lyon 2 (FR)
  • Cabinet de Psychiatrie du Plateau de Haye, 54320 Maxéville, France
  • UniDistance Suisse (CH)
Corresponding author
Putois, Benjamin
Venue
International Journal of Environmental Research and Public Health
Publisher
MDPI AG
Published
2021-09-28
Volume
18
Issue
19
Pages
10222
ISSN
1660-4601 (ISSN-L)
OpenAlex
W3204225041
Cited by
59
References
158
Citations by year
2026: 9 · 2025: 20 · 2024: 10 · 2023: 17 · 2022: 3
FWCI
1.23
Type
journal article
Language
en
Open access
Locations
  • International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, cc-by)
  • Le dépôt institutionnel (Université du Québec à Trois-Rivières) (submittedVersion)
  • IRIS (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
FONDATION ALCEA (XXX)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
Keywords
benzodiazepine discontinuation, cognitive behavioral therapy, acceptance and commitment therapy, insomnia, anxiety disorders, benzodiazepine withdrawal, benzodiazepine dependence, substance use disorders, chronic sleep disorders
MeSH terms
Anxiety Disorders, Benzodiazepines, Humans, Sleep Initiation and Maintenance Disorders, Substance Withdrawal Syndrome, Cognitive Behavioral Therapy, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders. https://app.cochat.ai/papers/10.3390/ijerph181910222
The paper
Chapoutot, M., Peter-Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R., Siclari, F., Nicolas, A., Lemoine, P., Higgins, S., Bourgeois, A., Vallet, G. T., Anders, R., Ounnoughene, M., Spencer, J., Meloni, F., & Putois, B. (2021). Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph181910222

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.